Didactics-Immunotherapy in Ovarian Cancers - What have we leart so far?

Immunotherapy in Ovarian Cancers - What have we leart so far?

Video Transcription

Video Summary

In this video, the speaker discusses the topic of immunotherapy in gynecological cancers, particularly ovarian cancer. They explain that immunotherapy, specifically immune checkpoint inhibitors, can potentially enhance the body's immune response to fight cancer cells. The speaker emphasizes the importance of combining immunotherapy with other treatment modalities, such as chemotherapy or PARP inhibitors, to improve outcomes for patients. They mention several clinical trials that have been conducted to assess the efficacy of various immunotherapy regimens in treating ovarian cancer. The speaker concludes by emphasizing the need for further research and clinical trials to better understand the potential benefits of immunotherapy, especially in patients with different genomic subtypes. Overall, the video highlights the current status and challenges in utilizing immunotherapy in the treatment of gynecological cancers. No credits were given in the video.

Asset Subtitle

Roger Ngan
April 2023

Keywords

immunotherapy

gynecological cancers

ovarian cancer

immune checkpoint inhibitors

chemotherapy

PARP inhibitors